Skip to main content
Premium Trial:

Request an Annual Quote

Knome Providing NGS Data Interpretation Solution to LabCentral Startups for Free

NEW YORK (GenomeWeb) – Knome today announced a sponsorship agreement to offer its next-generation sequencing data analysis system to startups in LabCentral's facility for free.

LabCentral was founded in late 2013 as a shared laboratory space to help launch high-potential life sciences and biotech startups. It currently hosts 25 companies in its Cambridge, Mass.-based facility and anticipates being at full capacity in the fall, Knome said.

Companies there will be able log into Knome's KnoSys Informatics and Genomic Interpretation System, located at the company's Cambridge facility, then upload their samples, analyze them, and export results. The startups also will have access to Knome's experts for training and support.

KnoSys is for clinical and translational medicine applications and offers a scalable, production-grade, customizable system for customers who want to bring in house the analysis of their NGS data. The solution is a fully integrated system for alignment, variant calling, annotation, multisample comparison, interpretation, variant classification, report content drafting, and storage of human genome sequence data. Version 3 of KnoSys was released last month.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.